Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of clinical response and cardiorespiratory endurance in early rheumatoid arthritis treated with tocilizumab or methotrexate
2010-019873-13Phase 2Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Apr 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of tocilizumab in rheumatoid arthritis (RA) (2 arms), sponsored by Cliniques universitaires Saint-Luc. Primary endpoints: Work capacity index (W65%/kg) at 6 months and Borg exertion score at 6 months. Started Apr 2010; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-019873-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019873-13.